Tobias Dylan Schad

Prior to joining Kirkland, Tobias was involved in the following matters:

• LaSalle Hotel Properties in its response to unsolicited public acquisition proposals from Pebblebrook Hotel Trust, leading to its proposed $4.8 billion sale to Blackstone in a “going private” transaction, and subsequent acceptance of topping bid from, and $5.2 billion cash and shares acquisition by, Pebblebrook Hotel Trust
• PAREXEL in its $5 billion sale to Pamplona Capital Management in a “going private” transaction
• Carbon Black in its $2.1 billion sale to VMware
• Amplify Snack Brands (the maker of SkinnyPop popcorn) in its $1.6 billion sale to Hershey
• Leaf Group in its $323 million sale to Graham Holdings Company 
• The Special Committee of the Board of Directors of NantKwest in NantKwest’s merger with ImmunityBio
• Control4 in its $680 million sale to SnapAV, a portfolio company of Hellman & Friedman
• Neon Therapeutics in its $97 million sale to BioNTech
• Neos Therapeutics in its all-stock merger with Aytu BioScience
• resTORbio in its “reverse” merger with Adicet Bio, and related contingent value right (CVR)